Vitamin K Dependent Modifications of Glutamic Acid Residues In

Total Page:16

File Type:pdf, Size:1020Kb

Vitamin K Dependent Modifications of Glutamic Acid Residues In Proc. Nat. Acad. Sci. USA Vol. 71, No. 7, pp. 2730-2733, July 1974 Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin (proton magnetic resonance spectroscopy/mass spectrometry) JOHAN STENFLO*, PER FERNLUND*, WILLIAM EGANt, AND PETER ROEPSTORFFt * Department of Clinical Chemistry, University of Lund, Malm6 General Hospital, 8-214 01 Malm6, Sweden; t Department of Physical Chemistry II, Lund Institute of Technology, Chemical Center, S-220 07 Lund, Sweden; and t The Danish Institute of Protein Chemistry, DK-2970 Horsholm, Denmark Communicated by Sune Bergstrom, May 9, 1974 ABSTRACT A tetrapeptide, residues 6 to 9 in normal hydrogen on the -y carbon atom by a carboxyl group. This prothrombin, was isolated from the NH2-terminal, Ca2+- work will be described in greater detail elsewhere. binding part of normal prothrombin. The electrophoretic mobility of the peptide was too high to be explained en- tirely by its amino-acid composition. According to 1H MATERIALS AND METHODS nuclear magnetic resonance spectroscopy and mass Isolation of Tetrapeptide. The heptapeptide from normal spectrometry, the peptide contained two residues of modi- fied glutamic acid, -y-carboxyglutamic acid (3-amino-1,1,3- prothrombin (residues 4 to 10) (ref. 13) was first thoroughly propanetricarboxylic acid), a hitherto unidentified amino digested with aminopeptidase M (Sigma) and afterwards with acid. This amino acid gives normal prothrombin the Ca2 +_ carboxypeptidase B (Sigma). A tetrapeptide was isolated binding ability that is necessary for its activation. Obser- from the digest by gel chromatography on Sephadex G-25 vations indicate that abnormal prothrombin, induced by the vitamin K antagonist, dicoumarol, lacks these modi- superfine and obtained in pure form as judged by high voltage fied glutamic acid residues and that this is the reason why electrophoresis at pH 6.5 (electrophoretic mobility relative to abnormal prothrombin does not bind Ca2+ and is non- that of aspartic acid 1.09) and amino-acid analysis (14), which functioning in blood coagulation. gave Glu 2.03, Val 0.97, and Leu 1.01. Prothrombin is a plasma glycoprotein that is activated during Synthesis of Leu-Glu-Glu-Val. Solid-phase technique (15) the process of blood coagulation to the proteolytic enzyme according to the procedures of Stewart and Young was used thrombin. The biosynthesis of prothrombin is vitamin K (16). The peptide was cleaved from the resin by treatment dependent, and deficiency of this vitamin or administration with 45% HBr in acetic acid and purified by gel chro- of the vitamin K antagonist, dicoumarol, gives rise to an matography on a Biogel P-2 column. The peptide was ho- abnormal prothrombin which does not function in blood mogeneous on paper electrophoresis at pH 6.5 (electrophoretic coagulation (1-6). The activation of prothrombin in vivo mobility relative to that of aspartic acid 0.84) and amino-acid requires the binding of Ca2+ (7); abnormal prothrombin does analysis gave Glu 2.07, Val 1.01, and Leu 0.92. not bind Ca2+ (2, 8, 9). During the activation of normal pro- thrombin an NH2-terminal fragment (molecular weight 1H Nuclear Magnetic Resonance Spectroscopy. The measure- approximately 25,000) is split off; the difference between ments were made with a Varian XL-100 spectrometer operat- abnormal and normal prothrombin has been localized to this ing in the Fourier transform mode; the deuterium resonance part of the molecule. Evidence has been produced that the from the solvent D20 (Ciba 99.8 atom percent) served as the difference is due to the lack of certain prosthetic groups in internal lock signal. The chemical shifts are given as 8 values abnormal prothrombin (10-13). and are relative to internal DSS (sodium 2,2-dimethylsila- In an endeavour to define the difference between normal pentane-5-sulfonate); a 60-jssec pulse width and, alternatively, and abnormal prothrombin, the NH2-terminal fragments from 1- and 2-sec acquisition times were used (changing the acquisi- both proteins were isolated and degraded further. A hepta- tion time had no observable effect on the spectrum). Before peptide from normal prothrombin (residues 4 to 10) and a spectra were recorded the lyophilized samples were disssolved corresponding heptapeptide from abnormal prothrombin were in D20 and taken to dryness two or three times in order to isolated by BrCN degradation and trypsin digestion. The substitute all exchangeable hydrogen with deuterium. heptapeptide from normal prothrombin differed from the peptide in abnormal prothrombin in that it had Mass Spectrometry. N-acetylation was done in methanol- corresponding The was then a higher anodal electrophoretic mobility at pH 6.5 (13). acetic anhydride (3:1, v/v). sample subjected to the permethylation procedure of Vilkas and Lederer (17) By extensive proteolytic digestion, the heptapeptide from Morris normal prothrombin was degraded to a tetrapeptide. This but with reduced reaction times as described by (18). The spectra were recorded with a Perkin Elmer 270 mass tetrapeptide, containing residues 6 to 9, still had an abnor- 1000. The mally high anodal electrophoretic mobility at pH 6.5. This spectrometer with a resolution of approximately acid ionizing energy was 70 eV and the ion source temperature was paper reports evidence that each of the two glutamic into the ion source' residues of this peptide are modified by replacement of one 1500. The sample was introduced directly and spectra were recorded repeatedly during slow heating of Abbreviations: DSS, sodium 2,2-dimethylsilapentane-5-sulfonate; the solids inlet probe. Evaporation of the sample occurred in NMR, nuclear magnetic resonance. the temperature range of 150 230°. 2730 Downloaded by guest on September 27, 2021 Proc. Nat. Acad. Sci. USA 71 (1974) Modified Glutamic Acid Residues in Prothrombin 2731 RESULTS A tetrapeptide was isolated from a heptapeptide which had the known sequence, Gly-Phe-Leu-Glx-Glx-Val-Arg (13) constituting residues 4 to 10 of normal prothrombin. It was inferred from its amino-acid composition that the tetrapeptide was Leu-Glx-Glx-Val. The yield from the heptapeptide was 64% or approximately 12% from intact normal prothrombin. The tetrapeptide had a high anodal electrophoretic mobility which seemed to be inconsistent with its amino-acid composi- tion even when the Glx residues were assumed to be glutamic acid (13). This inconsistency was confirmed when the mobility of the native tetrapeptide (1.09) was compared with that of a synthetic tetrapeptide Leu-Glu-Glu-Val (0.84). The native thus one extra .1 tetrapeptide possessed at least negative charge, possibly due to a prosthetic group. The 1H nuclear magnetic resonance spectrum of the syn- thetic tetrapeptide (Fig. 1) divides into three readily assign- able areas: the twelve methyl group protons (5 0.8-1.1); the four a protons (6 3.9-4.7); and the remaining 12 methylene and methine protons (b 1.5-2.6). The signals of this latter area appeared in three distinct groups, A, B, and C of Fig. 1, containing approximately (±0.5) 3.3, 4.6, and 4.2 protons, respectively. A tentative assignment of these resonances may _~~~~C A be made with the aid of 1H NMR charts given by Roberts and Jardetzky (19) together with the observation that, in the absence of a secondary or tertiary structure, the 1H NMR | I , I , spectrum of an oligo- or polypeptide is the superposition of 5.0 4.0 3.0 2.0 1.0 0 the spectra of the individual amino acids (19). Thus, the A j3 B FIG. 1. 1H nuclear magnetic resonance spectra (100 MHz) of peak includes the leucine and y protons, the peak the four the synthetic tetrapeptide (below) and native tetrapeptide glutamic acid # protons, and the C peak the four glutamic acid (above); the scale is in ppm (5), and relative to internal DSS. y protons; the valine ,3 protons are spread under both the B Concentrations of 14 mg and 0.9 mg in 0.25 ml of D20 were used and C regions. for the spectra of the synthetic and native tetrapeptide respec- Comparison of the NMR spectrum of the native peptide tively. (Fig. 1) with that of the synthetic tetrapeptide revealed no new resonances. Indeed, with one striking exception, the two substituted, the electron withdrawing power must be suffi- spectra were remarkably similar; while the region of the cient to render the remaining proton exchangeable). These native peptide corresponding to region A of the synthetic substituents, which could contain no inexchangeable hydro- peptide still contained approximately 3.3 protons, the region gens, must be labile enpugh to be removed under the condi- corresponding to B and C indicated loss of approximately four tions used for hydrolysis of the peptide (6 M HCl at 1100 for protons. Since acid hydrolysis of the native tetrapeptide gave 20 hr in vacuo). two glutamic acid residues, the difference could be explained The mass spectrum of the native tetrapeptide (Fig. 2) by the replacement of one or both of the hydrogens on the 'y shows that the conditions used for the derivation did not carbon of the glutamic acid residues (if only one hydrogen is cause N-methylation; the carboxyl groups, however, were AcLeu 4 Me2(COOH)Glu Me2(COOH)GIu - --- Val - fOMel 1 74 100 - 357 ._ 86 I9 0) 128 130 116 299 x5 14 6 l1 42 625 657 0 100 200 300 400 600 m e FIG. 2. Mass spectrum of acetylated and methyl esterified native tetrapeptide obtained at 190°-210°. Downloaded by guest on September 27, 2021 2732 Biochemistry: Stenflo et al. Proc. Nat. Acad. Sci. USA 71 (1974) C ,CH3 HOOC HCOOH HOOC COOH CH CHC s Ct-2 CH2 CH2 A CO-NH-CH-CO- NH-CH- CO-NH- CH-COOH B tK2NN-CH- S I.
Recommended publications
  • Subject Index
    Cambridge University Press 0521462924 - Amino Acids and Peptides G. C. Barrett and D. T. Elmore Index More information Subject index acetamidomalonate synthesis 123–4 in fossil dating 15 S-adenosyl--methionine 11, 12, 174, 181 in geological samples 15 alanine, N-acetyl 9 in Nature 1 structure 4 IR spectrometry 36 alkaloids, biosynthesis from amino acids 16–17 isolation from proteins 121 alloisoleucine 6 mass spectra 61 allosteric change 178 metabolism, products of 187 allothreonine 6 metal-binding properties 34 Alzheimer’s disease 14 NMR 41 amidation at peptide C-terminus 57, 94, 181 physicochemical properties 32 amides, cis–trans isomerism 20 protein 3 N-acylation 72 PTC derivatives 87 N-alkylation 72 quaternary ammonium salts 50 hydrolysis 57 reactions of amino group 49, 51 O-trimethylsilylation 72 reactions of carboxy group 49, 53 reduction to ␤-aminoalkanols 72 racemisation 56 amidocarbonylation in amino acid synthesis 125 routine spectrometry 35 amino acids, abbreviated names 7 Schöllkopf synthesis 127–8 acid–base properties 32 Schiff base formation 49 antimetabolites 200 sequence determination 97 et seq. as food additives 14 following selective chemical degradation 107 as neurotransmitters 17 following selective enzymic degradation 109 asymmetric synthesis 127 general strategy for 92 ␤- 17–18 identification of C-terminus 106–7 biosynthesis 121 identification of N-terminus 94, 97 biosynthesis from, of creatinine 183 by solid-phase methodology 100 of nitric oxide 186 by stepwise chemical degradation 97 of porphyrins 185 by use of dipeptidyl
    [Show full text]
  • A Few Experimental Suggestions Using Minerals to Obtain Peptides with a High Concentration of L-Amino Acids and Protein Amino Acids
    S S symmetry Hypothesis A Few Experimental Suggestions Using Minerals to Obtain Peptides with a High Concentration of L-Amino Acids and Protein Amino Acids Dimas A. M. Zaia 1,* and Cássia Thaïs B. V. Zaia 2 1 Laboratório de Química Prebiótica-LQP, Departamento de Química, Universidade Estadual de Londrina, CEP 86 057-970 Londrina, Brazil 2 Laboratório de Fisiologia Neuroendocrina e Metabolismo–LaFiNeM, Departamento de Ciências Fisiológicas, Universidade Estadual de Londrina, CEP 86 057-970 Londrina, Brazil; [email protected] * Correspondence: [email protected] Received: 9 October 2020; Accepted: 25 November 2020; Published: 10 December 2020 Abstract: The peptides/proteins of all living beings on our planet are mostly made up of 19 L-amino acids and glycine, an achiral amino acid. Arising from endogenous and exogenous sources, the seas of the prebiotic Earth could have contained a huge diversity of biomolecules (including amino acids), and precursors of biomolecules. Thus, how were these amino acids selected from the huge number of available amino acids and other molecules? What were the peptides of prebiotic Earth made up of? How were these peptides synthesized? Minerals have been considered for this task, since they can preconcentrate amino acids from dilute solutions, catalyze their polymerization, and even make the chiral selection of them. However, until now, this problem has only been studied in compartmentalized experiments. There are separate experiments showing that minerals preconcentrate amino acids by adsorption or catalyze their polymerization, or separate L-amino acids from D-amino acids. Based on the [GADV]-protein world hypothesis, as well as the relative abundance of amino acids on prebiotic Earth obtained by Zaia, several experiments are suggested.
    [Show full text]
  • Ratio of Phosphate to Amino Acids
    National Institute for Health and Care Excellence Final Neonatal parenteral nutrition [D10] Ratio of phosphate to amino acids NICE guideline NG154 Evidence reviews February 2020 Final These evidence reviews were developed by the National Guideline Alliance which is part of the Royal College of Obstetricians and Gynaecologists FINAL Error! No text of specified style in document. Disclaimer The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties. NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive.
    [Show full text]
  • Proteins, Peptides, and Amino Acids
    Proteins, Peptides, and Amino Acids Chandra Mohan, Ph.D. Calbiochem-Novabiochem Corp., San Diego, CA The Chemical Nature of Amino Acids Peptides and polypeptides are polymers of α-amino acids. There are 20 α-amino acids that make-up all proteins of biological interest. The α-amino acids in peptides and proteins α consist of a carboxylic acid (-COOH) and an amino (-NH2) functional group attached to the same tetrahedral carbon atom. This carbon is known as the -carbon. The type of R- group attached to this carbon distinguishes one amino acid from another. Several other amino acids, also found in the body, may not be associated with peptides or proteins. These non-protein-associated amino acids perform specialized functions. Some of the α-amino acids found in proteins are also involved in other functions in the body. For example, tyrosine is involved in the formation of thyroid hormones, and glutamate and aspartate act as neurotransmitters at fast junctions. R Amino acids exist in either D- or L- enantiomorphs or stereoisomers. The D- and L-refer to the absolute confirmation of optically active compounds. With the exception of glycine, all other amino acids are mirror images that can not be superimposed. Most of the amino acids found in nature are of the L-type. Hence, eukaryotic proteins are always composed of L-amino acids although D-amino acids are found in bacterial cell walls and in some peptide antibiotics. All biological reactions occur in an aqueous phase. Hence, it is important to know how the R-group of any given amino acid dictates the structure-function relationships of peptides and proteins in solution.
    [Show full text]
  • Dissociation Constants of Organic Acids and Bases
    DISSOCIATION CONSTANTS OF ORGANIC ACIDS AND BASES This table lists the dissociation (ionization) constants of over pKa + pKb = pKwater = 14.00 (at 25°C) 1070 organic acids, bases, and amphoteric compounds. All data apply to dilute aqueous solutions and are presented as values of Compounds are listed by molecular formula in Hill order. pKa, which is defined as the negative of the logarithm of the equi- librium constant K for the reaction a References HA H+ + A- 1. Perrin, D. D., Dissociation Constants of Organic Bases in Aqueous i.e., Solution, Butterworths, London, 1965; Supplement, 1972. 2. Serjeant, E. P., and Dempsey, B., Ionization Constants of Organic Acids + - Ka = [H ][A ]/[HA] in Aqueous Solution, Pergamon, Oxford, 1979. 3. Albert, A., “Ionization Constants of Heterocyclic Substances”, in where [H+], etc. represent the concentrations of the respective Katritzky, A. R., Ed., Physical Methods in Heterocyclic Chemistry, - species in mol/L. It follows that pKa = pH + log[HA] – log[A ], so Academic Press, New York, 1963. 4. Sober, H.A., Ed., CRC Handbook of Biochemistry, CRC Press, Boca that a solution with 50% dissociation has pH equal to the pKa of the acid. Raton, FL, 1968. 5. Perrin, D. D., Dempsey, B., and Serjeant, E. P., pK Prediction for Data for bases are presented as pK values for the conjugate acid, a a Organic Acids and Bases, Chapman and Hall, London, 1981. i.e., for the reaction 6. Albert, A., and Serjeant, E. P., The Determination of Ionization + + Constants, Third Edition, Chapman and Hall, London, 1984. BH H + B 7. Budavari, S., Ed., The Merck Index, Twelth Edition, Merck & Co., Whitehouse Station, NJ, 1996.
    [Show full text]
  • Isolation and Characterization of Vitamin K-Dependent Region Of
    Proc. Nat. Acad. Sci. USA Vol. 72, No. 4, pp. 1281-1285, April 1975 Isolation and Characterization of Vitamin K-Dependent Region of Bovine Blood Clotting Factor X (protein sequence/homology/calcium binding/-y-carboxyglutamic acid/coagulation) JAMES BRYANT HOWARD* AND GARY L. NELSESTUENt * Department of Biochemistry, College of Medicine 227 Millard Hall, University of Minnesota, Minneapolis, Minn. 55455; and t Department of Biochemistry, College of Biological Sciences, 140 Gortner Hall, University of Minnesota, St. Paul, Minn. 55101 Communicated by Emil L. Smith, January 17, 1975 ABSTRACT A 39-residue peptide from the tryptic di- that 8 of the 10 'y-carboxyglutamic acid residues are found in gestion of bovine blood clotting factor X has been isolated pairs (16, If the vitamin K-dependent blood clotting pro- by specific adsorption on barium citrate. The amino- and 1). carboxyl-terminal sequences of the peptide were deter- teins are related proteins, then homology between these mined and compared to the vitamin K-dependent Ca2+- proteins would be expected for the Ca2+-binding regions. We binding region from bovine prothrombin. The factor X wish to report the isolation and characterization of a peptide peptide was found to contain -y-carboxyglutamic acid resi- from factor X which is similar to the vitamin K-dependent, dues, and the results of independent analysis are con- sistent with all 14 glutamic acid residues as y-carboxy- Ca2+-binding region of prothrombin. Preliminary accounts of glutamic acid. The similarity of the factor X peptide to the some of this work have been presented (18, 20). prothrombin peptide supports the hypothesis that the vitamin K-dependent blood clotting proteins are de- METHODS AND MATERIALS scended from a common ancestral gene.
    [Show full text]
  • WO 2010/037397 Al
    (12) INTERNATIONALAPPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 8 April 2010 (08.04.2010) WO 2010/037397 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 38/17 (2006.01) C07K 14/705 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 47/48 (2006.01) GOlN 33/50 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/DK2009/050257 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 1 October 2009 (01 .10.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every PA 2008 0 1381 1 October 2008 (01 .10.2008) DK kind of regional protection available): ARIPO (BW, GH, 61/101,898 1 October 2008 (01 .10.2008) US GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, (71) Applicant (for all designated States except US): DAKO TM), European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, DENMARK A/S [DK/DK]; Produktionsvej 42, DK-2600 ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Glostrup (DK).
    [Show full text]
  • Novel Γ-Carboxyglutamic Acid-Containing Peptides from the Venom of Conus Textile
    Novel γ-Carboxyglutamic Acid-Containing Peptides from the Venom of Conus textile Eva Czerwiec1,2,€, Dario E. Kalume3#, Peter Roepstorff3, Björn Hambe4, Bruce Furie1,2, Barbara C. Furie1,2 and Johan Stenflo1,4. 1 Marine Biological Laboratory, Woods Hole, Ma, 02543, USA 2 Center for Hemostasis and Thrombosis Research, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA 3 Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense University, Campusvej 55, DK-5230 M, Odense. Denmark 4Department of Clinical Chemistry, Lund University, University Hospital, Malmö, S- 20502, Malmö, Sweden #Present address: McKusick-Nathans Institute of Genetic Medicine and the Department of Biological Chemistry, Johns Hopkins University, School of Medicine, Baltimore, MD 21287, USA €To whom correspondence should be sent. 2 Running title Gla-containing peptides from the venom of C. textile Corresponding author Eva Czerwiec, Marine Biological Laboratory, 7 MBL Street, Woods Hole, MA 02543, USA. Fax +1 508 540 6902. e-mail: [email protected] 1Abbreviations Gla, γ-carboxyglutamic acid; BrTrp: 6-L-bromotryptophan; Hyp: trans-4- hydroxyproline; γ-CRS, γ-carboxylation recognition site; CHAPS: 3-[(3- cholamidopropyl) dimethylammonio]-1-propanesulfonate; PCR: polymerase chain reaction; RACE-PCR: rapid amplification of cDNA ends-PCR 2 Non-standard bases: M = A or C; I = deoxyinosine; R = A or G; S = C or G; W = A or T; Y = C or T Key words γ-carboxyglutamic acid, vitamin K, conotoxin, Conus textile, propeptide 3 Abstract The cone snail is the only invertebrate system in which the vitamin K dependent carboxylase (or γ-carboxylase) and its product γ-carboxyglutamic acid (Gla)1 have been identified.
    [Show full text]
  • Functional Anthology of Intrinsic Disorder. 3. Ligands, Post-Translational Modifications, and Diseases Associated with Intrinsically Disordered Proteins
    Functional Anthology of Intrinsic Disorder. 3. Ligands, Post-Translational Modifications, and Diseases Associated with Intrinsically Disordered Proteins Hongbo Xie,² Slobodan Vucetic,² Lilia M. Iakoucheva,³ Christopher J. Oldfield,# A. Keith Dunker,# Zoran Obradovic,² and Vladimir N. Uversky*,#,§ Center for Information Science and Technology, Temple University, Philadelphia, Pennsylvania 19122, Laboratory of Statistical Genetics, The Rockefeller University, New York, New York 10021, Center for Computational Biology and Bioinformatics, Department of Biochemistry and Molecular Biology, Indiana University, School of Medicine, Indianapolis, Indiana 46202, and Institute for Biological Instrumentation, Russian Academy of Sciences, 142290 Pushchino, Moscow Region, Russia Received August 2, 2006 Currently, the understanding of the relationships between function, amino acid sequence, and protein structure continues to represent one of the major challenges of the modern protein science. As many as 50% of eukaryotic proteins are likely to contain functionally important long disordered regions. Many proteins are wholly disordered but still possess numerous biologically important functions. However, the number of experimentally confirmed disordered proteins with known biological functions is substantially smaller than their actual number in nature. Therefore, there is a crucial need for novel bionformatics approaches that allow projection of the current knowledge from a few experimentally verified examples to much larger groups of known and potential proteins. The elaboration of a bioinformatics tool for the analysis of functional diversity of intrinsically disordered proteins and application of this data mining tool to >200 000 proteins from the Swiss-Prot database, each annotated with at least one of the 875 functional keywords, was described in the first paper of this series (Xie, H.; Vucetic, S.; Iakoucheva, L.
    [Show full text]
  • Biochemistry
    Lecture -1 CHEMISTRY OF PROTEINS By/Assistant professor Dr. Naglaa F. Khedr 1 Objectives Functions of proteins Amino acids, types, properties Classification of amino acids Protein structures 2 Biological Functions of Proteins 1. Enzymes: regulate metabolism by selectively accelerating chemical reactions ( e.g. Ribonuclease) 2. Hormones – e.g. Insulin 3. Transport proteins – e.g. Hemoglobin, albumin. 4. Structural and support proteins – e.g. Collagen. 5. Contractile proteins – e.g. Actin & Myosin. 6. Immunity : defense against foreign substances ( e.g. Immunoglobulins) 7. Exotic proteins – e.g. Antifreeze proteins in fish. 3 Amino Acids are Building Blocks of Proteins R Different side chains, R, determine the properties of 20 amino acids. + NH3 C COO- Amino group Carboxylic H acid group Amino acids are the monomeric units or "building blocks" of proteins that are joined together covalently in peptide bonds, i.e., proteins are polymers of amino acids. .Amino acids are composed of amine (NH2) and carboxylic acid (COOH) functional groups, along with a side-chain specific to each amino acid. • Only 20 are commonly found as constituents of mammalian proteins. [Note: These are the only amino acids that are coded for by DNA, the genetic material in the cell • All amino acids have a common structural unit that is built around the alpha carbon. L-α-amino acids COOH H2N C H R R • R groups are the only variable groups in the structure All α-amino acids, except glycine, have an asymmetric carbon and thus, they have two enantiomers; D and L. L form
    [Show full text]
  • Coagulation Factor IX Analysis in Bioreactor Cell Culture Supernatant Predicts Quality of the Purified Product
    ARTICLE https://doi.org/10.1038/s42003-021-01903-x OPEN Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product Lucia F. Zacchi1,4, Dinora Roche-Recinos 1,2,4, Cassandra L. Pegg3, Toan K. Phung 3, Mark Napoli2, ✉ ✉ Campbell Aitken2, Vanessa Sandford2, Stephen M. Mahler1, Yih Yean Lee2 , Benjamin L. Schulz 1,3 & ✉ Christopher B. Howard1 Coagulation factor IX (FIX) is a complex post-translationally modified human serum glyco- protein and high-value biopharmaceutical. The quality of recombinant FIX (rFIX), especially 1234567890():,; complete γ-carboxylation, is critical for rFIX clinical efficacy. Bioreactor operating conditions can impact rFIX production and post-translational modifications (PTMs). With the goal of optimizing rFIX production, we developed a suite of Data Independent Acquisition Mass Spectrometry (DIA-MS) proteomics methods and used these to investigate rFIX yield, γ-carboxylation, other PTMs, and host cell proteins during bioreactor culture and after pur- ification. We detail the dynamics of site-specific PTM occupancy and structure on rFIX during production, which correlated with the efficiency of purification and the quality of the purified product. We identified new PTMs in rFIX near the GLA domain which could impact rFIX GLA- dependent purification and function. Our workflows are applicable to other biologics and expression systems, and should aid in the optimization and quality control of upstream and downstream bioprocesses. 1 ARC Training Centre for Biopharmaceutical Innovation, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD, Australia. 2 CSL Limited, Parkville, VIC, Australia. 3 School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia.
    [Show full text]
  • Federal Register/Vol. 86, No. 100/Wednesday, May 26, 2021/Proposed Rules
    Federal Register / Vol. 86, No. 100 / Wednesday, May 26, 2021 / Proposed Rules 28301 DEPARTMENT OF COMMERCE comments. Attachments to electronic expected to have a minimal impact on comments will be accepted in ADOBE® applicants in general. Patent and Trademark Office portable document format or The USPTO encourages applicants to MICROSOFT WORD® format. Because file their patent applications via its 37 CFR Part 1 comments will be made available for USPTO patent electronic filing system and imposes a surcharge for non- [Docket No. PTO–P–2020–0032] public inspection, information that the submitter does not desire to make electronic filing of an original patent RIN 0651–AD48 public, such as an address or phone application (excluding reissue, design, number, should not be included in the plant, and provisional applications), as Electronic Submission of a Sequence comments. mandated by section 10(h) of Public Listing, a Large Table, or a Computer Visit the Federal eRulemaking Portal Law 112–29, September 16, 2011 Program Listing Appendix in Patent (Leahy-Smith America Invents Act). The Applications website (www.regulations.gov) for additional instructions on providing USPTO provides information (Legal AGENCY: United States Patent and comments via the portal. If electronic Framework for Patent Electronic Trademark Office, Department of submission of comments is not feasible System) concerning electronic filing via Commerce. due to lack of access to a computer and/ the USPTO patent electronic filing system on its website at www.uspto.gov/ ACTION: Notice of proposed rulemaking. or the internet, please contact the USPTO using the contact information patents-application-process/filing- SUMMARY: The United States Patent and below for special instructions.
    [Show full text]